5 May 2023 - The agenda for the July 2023 PBAC meeting has been updated. 

A summary of changes to the agenda is provided at the end of the agenda document.

Resubmissions for the following medicines (vaccines) have been added to the agenda:

• Durvalumab (Imfinzi) - biliary tract cancer
• Nivolumab (Opdivo) - non-small-cell lung cancer
• Pembrolizumab (Keytruda) - breast cancer
• Varicella zoster virus vaccine (adjuvanted) - vaccination

Read PBS News